Drug treatments for breast cancer patients might soon be designed based on the unique genetic autograph of their tumor.
UK scientists have found a new way to slow the growth of the most aggressive type of breast cancer, according to research published in the journal Oncogene today.
A new study suggests that blocking an enzyme called PRMT5 in tumor cells could be a promising new strategy for the treatment of glioblastoma (GB), the most aggressive and lethal form of brain cancer.
Much of basic cancer research is based on studies with cultured cancer cells. However, the usefulness of these studies greatly depends on how accurately these cancer cells grown in a dish represent human tumors. A University ...
University of Queensland researchers have discovered a key driver in the development of most cancers, including breast, lung, liver and ovarian cancers.